About Viruj Pharma
Viruj Pharma is a company based in Hyderabad (India). The company has 44 employees as of March 31, 2024. Viruj Pharma offers products and services including Fluconazole and Fexofenadine.
- Headquarter Hyderabad, India
- Employees 44 as on 31 Mar, 2024
-
Sectors
Chemicals & MaterialsHealthcare
-
Email
***********
-
Phone
*********
- Legal Name Viruj Pharmaceuticals Private Limited
- Jurisdiction Hyderabad, Telangana, India
-
Annual Revenue
$5.92 M (USD)-46.78as on Mar 31, 2023
-
Net Profit
$149.49 K (USD)-71.98as on Mar 31, 2023
-
EBITDA
$239.97 K (USD)-81.96as on Mar 31, 2023
-
Latest Funding Round
-
Investors
-
Employee Count
44
as on Mar 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Viruj Pharma
Viruj Pharma offers a comprehensive portfolio of products and services, including Fluconazole and Fexofenadine.
Fluconazole is produced as an active pharmaceutical ingredient for antifungal treatments.
Fexofenadine is manufactured as an active pharmaceutical ingredient for antihistamine applications.
Funding Insights of Viruj Pharma
Investments & Acquisitions by Viruj Pharma
Financial Statements - Viruj Pharma
Viruj Pharma Comparisons
Competitors of Viruj Pharma
Latest news on Viruj Pharma
Frequently Asked Questions about Viruj Pharma
Viruj Pharma is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
As of Mar 31, 2024, the latest employee count at Viruj Pharma is 44.
Annual revenue of Viruj Pharma is $5.92M as on Mar 31, 2023.
Viruj Pharma is identified as a key API manufacturer based in Hyderabad, India, where a wide range of active pharmaceutical ingredients is produced, including Fluconazole and Fexofenadine. Strict quality standards such as Schedule M and ICH Q7 are adhered to, with processes involving continuous and batch manufacturing. Safety and environmental regulations are complied with through regular training and efforts to minimize impacts. The company serves global markets by developing complex APIs for therapy advantages, focusing on scale-up and commercial production.
Viruj Pharma offers Fluconazole and Fexofenadine.